ReviewDrug safety2014
Benefit-risk assessment of rosuvastatin in the treatment of atherosclerosis and related diseases.
Michael S Kostapanos et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
5 papers cite it
this papertrialcites it
ReviewDrug safety2014
Michael S Kostapanos et al.PubMed ↗Publisher ↗
No numbers read from the abstract.